RxDoctor Payments DataLook up a doctor →

Eyal Kedar, MD

Rheumatology · Canton, NYNPI 1457599532

Payments from drug & device makers

$1,879,999in general payments, 2019–2025

Across 247 payments — averaging $7611.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.1M
  • Eli Lilly$212K
  • AbbVie$185K
  • UCB SA$155K
  • AstraZeneca$73K
  • Pfizer$51K
  • plus $126K from 11 others
$21,756in research payments, 2019–2025

Across 16 payments — averaging $1359.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$14K
  • GSK$8K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis29$1,077,858
Eli Lilly16$211,907
AbbVie71$184,622
UCB SA29$155,040
AstraZeneca(2 entities)8$73,150
Pfizer22$51,458
GSK36$45,958
Genentech, Inc.11$41,568
Astrazeneca UK Limited6$18,290
Astrazeneca AB1$12,425
F. Hoffmann-la Roche AG3$3,700
Roche Products Limited3$3,306
Johnson & Johnson8$625
Boehringer Ingelheim1$42
Amgen1$26
E.r. Squibb & Sons, L.L.C.1$14
Genentech USA, Inc.1$11

How this compares

$1,879,999 in reported general payments places this provider in the 95th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York

Medicare billing

Part B allowed, 2024
$74,045
Medicare patients
329
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Canton

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →